AIM ImmunoTech and Shenzhen Smoore Technology announced research agreement to develop, easy-to-use treatment approach for the SARS-CoV-2 Pandemic
On Apr. 6, 2020, AIM ImmunoTech announced a Material Transfer and Research Agreement (MTA) with Shenzhen Smoore Technology…